Jiangsu Hengrui Pharmaceuticals Co. Ltd. (JHPCY)
OTC
Closed
Oct 7, 2026
Day's Range
12.5052 wk Range
11.50Overview - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Key Statistics
Valuation
Enterprise Value
2.26B
P/E (Trailing)
‪37.14‬
Price / Sales (TTM)
‪1.36‬
Price / Book
‪9.32‬
EV / EBITDA
‪0.23‬
Profitability
Gross Margin
‪86.02%‬
Profit Margin
‪86.20%‬
Operating Margin
‪27.57%‬
Return on Assets
‪11.03%‬
Return on Equity
‪12.47%‬
Ownership
Shares Outstanding
6.63B
Price stats
50-Day Avg
‪15.09‬
200-Day Avg
‪15.20‬
Dividends
Payout Ratio
‪17.16%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Peers - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)‪86.20%‬Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)‪14.57%‬Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)‪14.55%‬Profit Margin
- HNSPFOTCHansoh Pharmaceutical Group Company Limited25.76BMarket Cap-5.88%52-week change30.36P/E (Trailing)‪42.00%‬Profit Margin
Profile Summary - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
About
Jiangsu Hengrui Pharmaceuticals Co. Ltd. is a leading biopharmaceutical company engaged in the research, development, manufacture, and commercialization of innovative drugs primarily in China and internationally. It specializes in antineoplastic agents for cancer treatment, surgical anesthesia drugs, infusion…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
